ACCELERON PHARMA INC of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2010-07-21. The offering totals $11.5M, of which $10.3M was reported sold. Industry: Biotechnology.
Showing 25 of 30 people.
| Name | Role | Location |
|---|---|---|
| ANTHONY L EVNIN | Director | CAMBRIDGE, MA |
| PAT L GAGE | Director | CAMBRIDGE, MA |
| JEAN L GEORGE | Director | CAMBRIDGE, MA |
| ED L KANIA | Director | CAMBRIDGE, MA |
| TOM L MANIATIS | Director | CAMBRIDGE, MA |
| TERRY L MCGUIRE | Director | CAMBRIDGE, MA |
| RICHARD L POPS | Director | CAMBRIDGE, MA |
| WYLIE L VALE | Director | CAMBRIDGE, MA |
| PETER COUROSSI | Executive Officer | Chicago, IL |
| Jasbir Seehra | Executive Officer | Lexington, MA |
| Terrance G McGuire | Director | Boston, MA |
| Joseph S Zakrzewski | Director | Denver, CO |
| Jean M George | Director | Menlo Park, CA |
| Edwin M Kania, Jr. | Director | Rochester, MN |
| Carl L Gordon | Director | Stamford, CT |
| TOM G MANIATIS | Director | CAMBRIDGE, MA |
| MATTHEW L SHERMAN | Executive Officer | CAMBRIDGE, MA |
| JOHN KNOPF | Director | CAMBRIDGE, MA |
| JOHN KNOPF | Executive Officer | CAMBRIDGE, MA |
| GEORGE S GOLUMBESKI | Director | CAMBRIDGE, MA |
| KEVIN F MCLAUGHLIN | Executive Officer | CAMBRIDGE, MA |
| RICHARD F POPS | Director | CAMBRIDGE, MA |
| STEVEN G ERTEL | Executive Officer | CAMBRIDGE, MA |
| ANTHONY B EVNIN | Director | CAMBRIDGE, MA |
| ROBERT G STEININGER | Executive Officer | CAMBRIDGE, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2013-09-27 | D | $10.0M | $10.0M |
| 2012-01-04 | D | $30.5M | $30.5M |
| 2010-06-18 | D | $11.5M | $8.4M |
| 2009-12-15 | D | $11.0M | $11.0M |